Abstract: The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section.

Abstract: An infant and/or toddler nutrition comprising non-viable Bifidobacterium breve and a non-digestible oligosaccharide and its use are disclosed.

Abstract: The present invention concerns a therapy aimed at language and/or social skills in infants through administration of components stimulating the development of a healthy intestinal flora.

Abstract: The invention relates to a new strain of Lactobacillus salivarius, products containing the new strain, the use thereof in and methods for the treatment and/or prevention of inflammation and/or infection in breast or udder tissue, particularly in a mammary gland of a human female. The inflammation and/or infection is preferably mastitis.

Abstract: An exterminator for insects, for example mosquitoes, including: a) a container open on an upper side and filled with a water-containing fluid, including an inner wall with a smooth surface descending steeply towards the fluid, b) a cover at a distance above the open upper side of the container, and c) a float in the container, under the cover, and which can move up and down with the fluid level. The float includes a float body which extends above the surface of the fluid and which includes a structure which remains dry in a form of a gauze, net, cloth, screen, grid or fabric, on to which an electrostatic coating layer in a form of a platinum complex-containing silicone composition is provided.

Abstract: Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed.

Abstract: A composition comprising Bifidobacterium breve for use in improving lung function in human subjects suffering from dust mite allergy.

Abstract: An infant and/or toddler nutrition comprising non-viable Bifidobacterium breve and a non-digestible oligosaccharide and its use are disclosed.

Abstract: A composition comprising Bifidobacterium breve, a non-digestible saccharide A and a non-digestible saccharide B, optionally combined with Lactobacillus paracasei and the use of said composition for the treatment and/or prevention of gastro-intestinal disorder, immune disorder and/or endocrine disorder.

Abstract: A nutritional composition comprising a combination of non-digestible oligosaccharides and a product obtained by incubating an aqueous substrate by bifidobacteria and optionally a product obtained by incubating an aqueous substrate by S. thermophilus. Said combination reduces bacterial translocation and improves the intestinal barrier function.

Abstract: A composition comprising Bifidobacterium breve, a non-digestible saccharide A and a non-digestible saccharide B, optionally combined with Lactobacillus paracasei and the use of said composition for the treatment and/or prevention of gastro-intestinal disorder, immune disorder and/or endocrine disorder.

Abstract: The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants.

Abstract: There is provided a preparation comprising Bifidobacterium breve and a mixture of non-digestible carbohydrates for non- or partially breast-fed infants as well as the use thereof for the treatment or prevention of immune disorder in non- or partially breast-fed infants. Also provided herein are sequence primers and probe for the detection of Bifidobacterium species as well as diagnostic kit thereof.

Abstract: The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section.

Abstract: The present invention relates to compositions containing probiotic bacteria and uronic acid oligosaccharides. The compositions can suitably be used as infant nutrition and advantageously reduce the incidence of infection.

Abstract: A composition comprising Bifidobacterium breve for use in improving lung function in human subjects suffering from dust mite allergy.

Abstract: A food or supplement for pregnant women comprising water soluble, non-digestible saccharides is described. The composition is used to improve the flora and/or immune system of the pregnant women, to improve the immune system of the infant and to improve the intestinal flora of the infant after birth.

Abstract: A composition comprising Bifidobacterium breve for use in improving lung function in human subjects suffering from dust mite allergy.

Abstract: The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section.

Abstract: A description is given of an exterminator (1) for insects, in particular mosquitoes, comprising: a) a container (2) which is open on the upper side and which is to be filled with a water-containing fluid, having an inner wall with a smooth surface descending steeply towards the water, b) a cover (4) provided at a distance above the open upper side of the container, and c) a float (7) which is provided in the container, under the cover, and which can move up and down with the fluid level, which float has a float body (9) which extends above the surface of the fluid and which comprises or is provided with a structure (10) which remains dry in the form of a gauze, net, cloth, screen, grid or fabric, on to which an electrostatic coating layer in the form of a platinum complex-containing silicone composition is provided, to which one or more powders are adhered which comprise:—a juvenile hormone, such as pyriproxyphene and/or—a fungus, such as Beauveria bassiana, and/or Metarhizium anisopliae, and/or—an intensifyi